Enzo Biochem

Quarterly Financials

Values in thousands 2024-07-31 2024-04-30 2024-01-31 2023-10-31
Revenue
$7,526
$8,022
$8,553
$7,806
Gross Profit
3,220
3,733
4,224
3,455
EBITDA
-2,049
-1,014
-863
-4,131
EBIT
-2,447
-1,351
-1,130
-4,401
Net Income
-13,381
-3,020
-3,061
-6,616
Net Change In Cash
7,526
8,022
8,553
7,806
Free Cash Flow
-1,208
-3,005
-8,963
-13,628
Cash
52,371
62,156
65,241
69,207
Basic Shares
52,244
51,214
50,490
50,184

Annual Financials

Values in thousands 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Revenue
$31,907
$31,061
$107,071
$117,731
Gross Profit
14,632
11,566
41,967
53,577
EBITDA
-8,348
-20,941
-15,007
3,345
EBIT
-9,620
-23,623
-17,834
692
Net Income
-26,078
20,288
-22,578
3,425
Net Change In Cash
31,907
31,061
107,071
117,731
Cost of Revenue
8,392
Free Cash Flow
-26,804
-39,736
-20,062
-4,049
Cash
52,371
82,373
21,603
13,524
Basic Shares
50,902
49,160
48,594
48,325

Earnings Calls

Quarter EPS
2024-07-31
-$0.25
2024-04-30
-$0.05
2024-01-31
-$0.06
2023-10-31
-$0.13